Patents for Critical Pharmaceuticals: The AZT Case
American Journal of Law and Medicine. 1991; 17(1 and 2): 145-180.
Patents and other statutory types of market protections are used in the United States to promote scientific research and innovation. This incentive is especially important in research intensive fields such as the pharmaceutical industry. Unfortunately, these same protections often result in higher monopoly pricing once a successful product is brought to market...However, in the case of the AIDS drug Zidovudine (AZT), the high prices charged by the pharmaceutical company owning the drug have led to public outcry and a re-examination of government incentive systems. This Note traces the evolution of these incentive programs...Finally, it describes how Congress and the courts have attempted to resolve these problems in the past, and how they might best try to solve the AZT problem in the near future.
Aids; Biomedical Research; Drug Industry; Drugs; Economics; Evolution; Federal Government; Food; Government; Government Regulation; HIV Seropositivity; Incentives; Industry; Legal Aspects; Patents; Patient Care; Property Rights; Public Policy; Pharmaceutical Industry; Property; Regulation; Research; Rights; Supreme Court Decisions;
Showing items related by title, author, creator and subject.